[HTML] cell.comFull View

[HTML][HTML] Forelimb treatment in a large cohort of dystrophic dogs supports delivery of a recombinant AAV for exon skipping in Duchenne patients

C Le Guiner, M Montus, L Servais, Y Cherel… - Molecular Therapy, 2014 - cell.com
Duchenne muscular dystrophy (DMD) is a severe muscle-wasting disorder caused by
mutations in the dystrophin gene, without curative treatment yet available. Our study …
被引用次数：134 相关文章

Forelimb Treatment in a Large Cohort of Dystrophic Dogs Supports Delivery of a Recombinant AAV for Exon Skipping in Duchenne Patients

C Le Guiner, M Montus, L Servais, Y Cherel… - Molecular …, 2014 - hal.science
Duchenne muscular dystrophy (DMD) is a severe muscle-wasting disorder caused by
mutations in the dystrophin gene, without curative treatment yet available. Our study …
[HTML] sciencedirect.com

[HTML][HTML] Forelimb Treatment in a Large Cohort of Dystrophic Dogs Supports Delivery of a Recombinant AAV for Exon Skipping in Duchenne Patients

C Le Guiner, M Montus, L Servais, Y Cherel… - Molecular Therapy, 2014 - Elsevier
Duchenne muscular dystrophy (DMD) is a severe muscle-wasting disorder caused by
mutations in the dystrophin gene, without curative treatment yet available. Our study …

[引用][C] Forelimb Treatment in a Large Cohort of Dystrophic Dogs Supports Delivery of a Recombinant AAV for Exon Skipping in Duchenne Patients

C Le Guiner, M Montus, L Servais, Y Cherel… - Molecular …, 2014 - cir.nii.ac.jp
Forelimb Treatment in a Large Cohort of Dystrophic Dogs Supports Delivery of a
Recombinant AAV for Exon Skipping in Duchenne Patients | CiNii Research CiNii 国立 …

Forelimb Treatment in a Large Cohort of Dystrophic Dogs Supports Delivery of a Recombinant AAV for Exon Skipping in Duchenne Patients.

C Le Guiner, M Montus, L Servais, Y Cherel… - Molecular …, 2014 - search.ebscohost.com
Duchenne muscular dystrophy (DMD) is a severe muscle-wasting disorder caused by
mutations in the dystrophin gene, without curative treatment yet available. Our study …

Forelimb Treatment in a Large Cohort of Dystrophic Dogs Supports Delivery of a Recombinant AAV for Exon Skipping in Duchenne Patients

C Le Guiner, M Montus, L Servais, Y Cherel… - Molecular …, 2014 - inserm.hal.science
Duchenne muscular dystrophy (DMD) is a severe muscle-wasting disorder caused by
mutations in the dystrophin gene, without curative treatment yet available. Our study …

Forelimb treatment in a large cohort of dystrophic dogs supports delivery of a recombinant AAV for exon skipping in Duchenne patients.

C Le Guiner, M Montus, L Servais, Y Cherel… - … Therapy: the Journal …, 2014 - europepmc.org
Duchenne muscular dystrophy (DMD) is a severe muscle-wasting disorder caused by
mutations in the dystrophin gene, without curative treatment yet available. Our study …
[HTML] nih.gov

[HTML][HTML] Forelimb Treatment in a Large Cohort of Dystrophic Dogs Supports Delivery of a Recombinant AAV for Exon Skipping in Duchenne Patients

C Le Guiner, M Montus, L Servais, Y Cherel… - Molecular …, 2014 - ncbi.nlm.nih.gov
Duchenne muscular dystrophy (DMD) is a severe muscle-wasting disorder caused by
mutations in the dystrophin gene, without curative treatment yet available. Our study …

Forelimb Treatment in a Large Cohort of Dystrophic Dogs Supports Delivery of a Recombinant AAV for Exon Skipping in Duchenne Patients

C Le Guiner, M Montus, L Servais, Y Cherel… - Molecular …, 2014 - search.proquest.com
Duchenne muscular dystrophy (DMD) is a severe muscle-wasting disorder caused by
mutations in the dystrophin gene, without curative treatment yet available. Our study …

Forelimb Treatment in a Large Cohort of Dystrophic Dogs Supports Delivery of a Recombinant AAV for Exon Skipping in Duchenne Patients

C Le Guiner, M Montus, L Servais, Y Cherel, V François… - 2014 - agris.fao.org
Duchenne muscular dystrophy (DMD) is a severe muscle-wasting disorder caused by
mutations in the dystrophin gene, without curative treatment yet available. Our study …